Who can benefit from treatment with ARESTIN®?
A. Many patients with periodontal disease can benefit from ARESTIN®. However, ARESTIN® should not be used in any patient who has a known allergy or sensitivity to minocycline or tetracycline. In addition, ARESTIN® should not be used in children or in patients who are pregnant or nursing a baby. The use of ARESTIN® in an acutely abscessed periodontal pocket has not been studied and is not recommended. While no overgrowth by opportunistic microorganisms, such as yeast, were noted during clinical studies, as with other antimicrobials, the use of ARESTIN® may result in overgrowth of nonsusceptible microorganisms including fungi. The effects of treatment for greater than 6 months has not been studied. ARESTIN® should be used with caution in patients having a history of predisposition to oral candidiasis. ARESTIN® has not been clinically tested in immunocompromised patients (such as those immunocompromised by diabetes, chemotherapy, radiation therapy, or infection with HIV). If superinfectio
